{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:18:06Z","timestamp":1789885086162,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microvascular Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.mvr.2018.03.012","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T23:28:24Z","timestamp":1522106904000},"page":"7-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"special_numbering":"C","title":["Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy?"],"prefix":"10.1016","volume":"119","author":[{"given":"Matthew F.","family":"Yuyun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leong L.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Andr\u00e9","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.mvr.2018.03.012_bb0005","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/CIRCULATIONAHA.106.612325","article-title":"5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling","volume":"114","author":"Antoniades","year":"2006","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.mvr.2018.03.012_bb0010","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1161\/01.ATV.17.10.1846","article-title":"Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences","volume":"17","author":"Balligand","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.mvr.2018.03.012_bb0015","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1093\/ndt\/gfm402","article-title":"Improvement of endothelial function in uraemic patients on peritoneal dialysis: a possible role for 5-MTHF administration","volume":"22","author":"Baragetti","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"issue":"18","key":"10.1016\/j.mvr.2018.03.012_bb0020","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1089\/ars.2013.5566","article-title":"Tetrahydrobiopterin in cardiovascular health and disease","volume":"20","author":"Bendall","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"23","key":"10.1016\/j.mvr.2018.03.012_bb0025","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1161\/01.CIR.98.23.2520","article-title":"Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis","volume":"98","author":"Brattstrom","year":"1998","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.mvr.2018.03.012_bb0030","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/ndt\/17.5.857","article-title":"5-methyltetrahydrofolate restores endothelial function in uraemic patients on convective haemodialysis","volume":"17","author":"Buccianti","year":"2002","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/j.mvr.2018.03.012_bb0035","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0899-9007(00)00289-6","article-title":"Low serum folate but normal homocysteine levels in patients with atherosclerotic vascular disease and matched healthy controls","volume":"16","author":"Bunout","year":"2000","journal-title":"Nutrition"},{"issue":"9","key":"10.1016\/j.mvr.2018.03.012_bb0040","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1089\/ars.2012.4824","article-title":"Nitric oxide synthases in heart failure","volume":"18","author":"Carnicer","year":"2013","journal-title":"Antioxid. Redox Signal."},{"issue":"16","key":"10.1016\/j.mvr.2018.03.012_bb0045","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke - a meta-analysis","volume":"288","author":"Clarke","year":"2002","journal-title":"JAMA"},{"issue":"41","key":"10.1016\/j.mvr.2018.03.012_bb0050","doi-asserted-by":"crossref","first-page":"28128","DOI":"10.1074\/jbc.M109.041483","article-title":"Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: relative importance of the de novo biopterin synthesis versus salvage pathways","volume":"284","author":"Crabtree","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.mvr.2018.03.012_bb0055","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1161\/CIRCULATIONAHA.111.038919","article-title":"Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease","volume":"125","author":"Cunnington","year":"2012","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.mvr.2018.03.012_bb0060","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.mvr.2018.03.012_bb0065","first-page":"1983","article-title":"Endothelial dysfunction","volume":"15","author":"Endemann","year":"2004","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.mvr.2018.03.012_bb0070","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00424-010-0808-2","article-title":"Nitric oxide and oxidative stress in vascular disease","volume":"459","author":"Forstermann","year":"2010","journal-title":"Pflugers Arch."},{"issue":"7","key":"10.1016\/j.mvr.2018.03.012_bb0075","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.freeradbiomed.2010.12.018","article-title":"Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders","volume":"50","author":"Gielis","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"19","key":"10.1016\/j.mvr.2018.03.012_bb0080","doi-asserted-by":"crossref","first-page":"7008","DOI":"10.1073\/pnas.0408919102","article-title":"5-Methyltetrahydrofolate and tetrahydrobiopterin can modulate electrotonically mediated endothelium-dependent vascular relaxation","volume":"102","author":"Griffith","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.mvr.2018.03.012_bb0085","first-page":"282","article-title":"Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after long-term therapy","volume":"18","author":"van Guldener","year":"1998","journal-title":"Perit. Dial. Int."},{"issue":"4","key":"10.1016\/j.mvr.2018.03.012_bb0090","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.ATV.0000258946.55438.0e","article-title":"Oral administration of tetrahydrobiopterin slows the progression of atherosclerosis in apolipoprotein E-knockout mice","volume":"27","author":"Hattori","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.mvr.2018.03.012_bb0095","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ajcn\/82.4.806","article-title":"Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials","volume":"82","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"issue":"6","key":"10.1016\/j.mvr.2018.03.012_bb0100","article-title":"Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function","volume":"282","author":"Hyndman","year":"2002","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.mvr.2018.03.012_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e3533","article-title":"The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis","volume":"344","author":"Jardine","year":"2012","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.mvr.2018.03.012_bb0110","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1161\/01.ATV.0000189559.87328.e4","article-title":"Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation","volume":"25","author":"Jiang","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"Pt 2","key":"10.1016\/j.mvr.2018.03.012_bb0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj2980249","article-title":"Nitric oxide synthases in mammals","volume":"298","author":"Knowles","year":"1994","journal-title":"Biochem. J."},{"issue":"25","key":"10.1016\/j.mvr.2018.03.012_bb0120","doi-asserted-by":"crossref","first-page":"22546","DOI":"10.1074\/jbc.M302227200","article-title":"Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase","volume":"278","author":"Kuzkaya","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.mvr.2018.03.012_bb0125","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/01.CIR.103.9.1282","article-title":"Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin","volume":"103","author":"Laursen","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.mvr.2018.03.012_bb0130","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/STROKEAHA.109.573410","article-title":"Efficacy of homocysteine-lowering therapy with folic acid in stroke prevention: a meta-analysis","volume":"41","author":"Lee","year":"2010","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.mvr.2018.03.012_bb0135","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003768","article-title":"Folic acid supplementation and the risk of cardiovascular diseases: a meta-analysis of randomized controlled trials","volume":"5","author":"Li","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.mvr.2018.03.012_bb0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2014.03.032","article-title":"The effect of homocysteine-lowering therapy with folic acid on flow-mediated vasodilation in patients with coronary artery disease: a meta-analysis of randomized controlled trials","volume":"235","author":"Liu","year":"2014","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.mvr.2018.03.012_bb0145","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/cvr\/cvr360","article-title":"Nitric oxide synthase in post-ischaemic remodelling: new pathways and mechanisms","volume":"94","author":"Manoury","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mvr.2018.03.012_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006612.pub3","article-title":"Homocysteine-lowering interventions for preventing cardiovascular events","volume":"1","author":"Marti-Carvajal","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.mvr.2018.03.012_bb0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/ajcn\/77.1.63","article-title":"Thermolabile methylenetetrahydrofolate reductase, homocysteine, and cardiovascular disease risk: the European Concerted Action Project","volume":"77","author":"Meleady","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.mvr.2018.03.012_bb0160","first-page":"216","article-title":"The methylation, neurotransmitter, and antioxidant connections between folate and depression","volume":"13","author":"Miller","year":"2008","journal-title":"Altern. Med. Rev."},{"issue":"4","key":"10.1016\/j.mvr.2018.03.012_bb0165","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.amjcard.2010.03.064","article-title":"Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels","volume":"106","author":"Miller","year":"2010","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.mvr.2018.03.012_bb0170","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jnutbio.2003.08.010","article-title":"Folate, homocysteine, endothelial function and cardiovascular disease","volume":"15","author":"Moat","year":"2004","journal-title":"J. Nutr. Biochem."},{"issue":"1","key":"10.1016\/j.mvr.2018.03.012_bb0175","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1631\/jzus.B1400183","article-title":"Elevated homocysteine levels and risk of cardiovascular and all-cause mortality: a meta-analysis of prospective studies","volume":"16","author":"Peng","year":"2015","journal-title":"J Zhejiang Univ Sci B"},{"issue":"3","key":"10.1016\/j.mvr.2018.03.012_bb0180","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2215\/CJN.05310610","article-title":"Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: a meta-analysis","volume":"6","author":"Qin","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.mvr.2018.03.012_bb0185","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pharmthera.2013.07.004","article-title":"Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?","volume":"140","author":"Rochette","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"5\u20136","key":"10.1016\/j.mvr.2018.03.012_bb0190","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.vph.2012.02.004","article-title":"Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases","volume":"57","author":"Roe","year":"2012","journal-title":"Vasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.mvr.2018.03.012_bb0195","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1042\/CS20090559","article-title":"Tetrahydrobiopterin supplementation reduces atherosclerosis and vascular inflammation in apolipoprotein E-knockout mice","volume":"119","author":"Schmidt","year":"2010","journal-title":"Clin. Sci."},{"issue":"6","key":"10.1016\/j.mvr.2018.03.012_bb0200","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.RES.0000217594.97174.c2","article-title":"Coupled and uncoupled NOS: separate but equal? Uncoupled NOS in endothelial cells is a critical pathway for intracellular signaling","volume":"98","author":"Sullivan","year":"2006","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.mvr.2018.03.012_bb0205","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1074\/jbc.272.2.1276","article-title":"Subunit interactions of endothelial nitric-oxide synthase. Comparisons to the neuronal and inducible nitric-oxide synthase isoforms","volume":"272","author":"Venema","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"7374","key":"10.1016\/j.mvr.2018.03.012_bb0210","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"Br. Med. J."},{"issue":"9576","key":"10.1016\/j.mvr.2018.03.012_bb0215","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(07)60854-X","article-title":"Efficacy of folic acid supplementation in stroke prevention: a meta-analysis","volume":"369","author":"Wang","year":"2007","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.mvr.2018.03.012_bb0220","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.numecd.2011.04.011","article-title":"Folate and risk of coronary heart disease: a meta-analysis of prospective studies","volume":"22","author":"Wang","year":"2012","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.mvr.2018.03.012_bb0225","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/850312","article-title":"Tetrahydrobiopterin improves endothelial function in cardiovascular disease: a systematic review","volume":"2014","author":"Wang","year":"2014","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"8","key":"10.1016\/j.mvr.2018.03.012_bb0230","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ejim.2012.07.004","article-title":"Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials","volume":"23","author":"Yang","year":"2012","journal-title":"Eur. J. Intern. Med."},{"issue":"5","key":"10.1016\/j.mvr.2018.03.012_bb0235","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3892\/etm.2014.1553","article-title":"Efficacy of folic acid supplementation on endothelial function and plasma homocysteine concentration in coronary artery disease: a meta-analysis of randomized controlled trials","volume":"7","author":"Yi","year":"2014","journal-title":"Exp. Ther. Med."},{"issue":"9","key":"10.1016\/j.mvr.2018.03.012_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025142","article-title":"Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis","volume":"6","author":"Zhou","year":"2011","journal-title":"PLoS One"}],"container-title":["Microvascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286217301978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286217301978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T09:23:09Z","timestamp":1570958589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026286217301978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":48,"alternative-id":["S0026286217301978"],"URL":"https:\/\/doi.org\/10.1016\/j.mvr.2018.03.012","relation":{},"ISSN":["0026-2862"],"issn-type":[{"value":"0026-2862","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy?","name":"articletitle","label":"Article Title"},{"value":"Microvascular Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mvr.2018.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}